Authors
Loading...
Randomized trial demonstrates SET8's role in promoting tumor progression in pancreatic ductal adenocarcinoma, suggesting new therapeutic avenues.
Liu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: